Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer treatment by developing a new therapy, called photosensitive hybrid γδ-T exosomes (hybrid γδ-T-Exos). This therapy targets and destroys cancer cells, while promoting the release of damage-associated molecular patterns (DAMPs) and boosting the subsequent antigen-specific immune response. In laboratory tests and animal studies, this innovative hybrid therapy showed a significant reduction in melanoma growth, leading to more effective and safer treatments for cancers. The findings were published in the scientific journal ACS Nano.
